What is he best known for?
The fields of study he is best known for:
- Cancer
- Gene
- Internal medicine
His primary scientific interests are in Cancer research, Pathology, Thyroid, Internal medicine and Thyroid carcinoma.
Giovanni Tallini has researched Cancer research in several fields, including Beta-catenin, Anaplastic thyroid cancer, Carcinogenesis, Catenin and Integrin.
His Pathology research includes elements of Tumor progression and Karyotype.
His work in Thyroid tackles topics such as Mutation which are related to areas like Mitochondrial DNA.
The concepts of his Internal medicine study are interwoven with issues in Immunology, Endocrinology and Oncology.
His Thyroid carcinoma research is multidisciplinary, relying on both Cancer, Adenocarcinoma and Gene rearrangement.
His most cited work include:
- BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer (771 citations)
- MGMT Promoter Methylation Status Can Predict the Incidence and Outcome of Pseudoprogression After Concomitant Radiochemotherapy in Newly Diagnosed Glioblastoma Patients (616 citations)
- RAS Point Mutations and PAX8-PPARγ Rearrangement in Thyroid Tumors: Evidence for Distinct Molecular Pathways in Thyroid Follicular Carcinoma (556 citations)
What are the main themes of his work throughout his whole career to date?
Pathology, Cancer research, Thyroid, Internal medicine and Thyroid carcinoma are his primary areas of study.
His Pathology research includes themes of Karyotype and Cytogenetics.
His Cancer research research is multidisciplinary, incorporating elements of Carcinogenesis, Gene, Mutation and Exon.
His Thyroid study combines topics in areas such as Phenotype and Cancer.
His work carried out in the field of Internal medicine brings together such families of science as Gastroenterology, Endocrinology, Surgery and Oncology.
His research combines Gene rearrangement and Thyroid carcinoma.
He most often published in these fields:
- Pathology (45.53%)
- Cancer research (28.05%)
- Thyroid (24.80%)
What were the highlights of his more recent work (between 2016-2021)?
- Internal medicine (23.17%)
- Thyroid (24.80%)
- Oncology (9.76%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Internal medicine, Thyroid, Oncology, Cancer research and Gene.
He works mostly in the field of Internal medicine, limiting it down to concerns involving IDH1 and, occasionally, Mean age.
His research in Thyroid intersects with topics in Persistent Disease, Risk stratification and Pathology.
His Pathology study typically links adjacent topics like Tumor size.
Giovanni Tallini interconnects Immunohistochemistry, Tenascin, Who classification, Wild type and Exon in the investigation of issues within Cancer research.
His work on Mutation, KRAS and Tumor progression as part of his general Gene study is frequently connected to Hepatic stellate cell activation, thereby bridging the divide between different branches of science.
Between 2016 and 2021, his most popular works were:
- Predictive molecular pathology in the time of coronavirus disease (COVID-19) in Europe. (14 citations)
- Low grade glioma patients with IDH mutation and 1p19q codeletion: To treat or not to treat? (10 citations)
- Real-World Performance of the American Thyroid Association Risk Estimates in Predicting 1-Year Differentiated Thyroid Cancer Outcomes: A Prospective Multicenter Study of 2000 Patients. (6 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Gene
- Internal medicine
His main research concerns Thyroid, Cancer research, Internal medicine, Exon and Gene.
His Thyroid study incorporates themes from Multivariate analysis and Lymph node, Cohort, Pathology.
The concepts of his Pathology study are interwoven with issues in Tumor size, Risk stratification and Univariate analysis.
His study ties his expertise on Thyroid carcinoma together with the subject of Cancer research.
Giovanni Tallini combines subjects such as Carcinoma, Endometrial cancer and PTEN with his study of Gene.
Giovanni Tallini usually deals with Thyroid cancer and limits it to topics linked to Anaplastic carcinoma and Immunohistochemistry.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
